CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC

Develops and manufactures diagnostic tests for food sensitivity and gut health.

CNSL | IL

Overview

Corporate Details

ISIN(s):
GB00B1CS9459 (+1 more)
LEI:
2138007U9P4BTZTYIR92
Country:
United Kingdom
Address:
EDEN RESEARCH PARK, CB6 1SE LITTLEPORT
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company that develops, manufactures, and distributes diagnostic products for the food sensitivity testing market. The company promotes a personalized and functional approach to health, specializing in a range of tests associated with food sensitivity and gut health. Utilizing advanced diagnostic technology, it enables healthcare professionals and their patients to identify potential dietary and lifestyle changes to improve long-term wellbeing. As a pioneer in its field, the company leverages its expertise to provide tools for managing health through nutrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 08:25
Report Publication Announcement
Notice of Results & Investor Presentation
English 13.6 KB
2025-09-25 17:30
Post-Annual General Meeting Information
Result of AGM
English 9.2 KB
2025-08-28 08:00
Report Publication Announcement
Notice of AGM & Annual Report
English 9.3 KB
2025-08-21 08:00
Remuneration Information
Grant of Options
English 17.1 KB
2025-08-19 08:00
Annual Report
Final Results
English 941.0 KB
2025-07-31 08:00
Report Publication Announcement
Notice of Results & Investor Presentation
English 13.8 KB
2025-07-10 08:00
Board/Management Information
Directorate Change
English 18.8 KB
2025-07-02 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-05-27 08:00
Earnings Release
Trading Update
English 14.1 KB
2025-05-23 08:00
Legal Proceedings Report
Resolution on HSE Matter
English 13.5 KB
2025-03-19 08:00
Legal Proceedings Report
Omega Diagnostics Summons Update
English 12.1 KB
2025-03-18 15:48
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-02-06 08:00
Director's Dealing
Director/PDMR Shareholding
English 30.7 KB
2025-01-30 10:41
Director's Dealing
Director/PDMR Shareholding
English 30.7 KB
2025-01-21 17:03
Legal Proceedings Report
Omega Diagnostics court summons
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE NUTRITIONAL SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
LAVA Therapeutics NV Logo
Develops bispecific gamma delta T cell engagers for solid and hematologic cancers.
United States of America LVTX
Lavipharm S.A. Logo
Develops & distributes Rx/OTC medicines, supplements & cosmetics for key therapeutic areas.
Greece LAVI
Clinical-stage biopharma developing oral therapies for neuropsychiatric diseases like schizophrenia.
United States of America LBRX
Legend Biotech Corp Logo
Develops and commercializes CAR-T cell therapies for cancer, including CARVYKTI® for myeloma.
United States of America LEGN
LENZ Therapeutics, Inc. Logo
Develops a prescription eye drop for presbyopia, the age-related loss of near vision.
United States of America LENZ
Lexaria Bioscience Corp. Logo
Biotech firm with patented technology improving oral drug delivery and absorption.
United States of America LEXX
Lexeo Therapeutics, Inc. Logo
Develops AAV gene therapies for genetic cardiovascular and Alzheimer's diseases.
United States of America LXEO
LEXICON PHARMACEUTICALS, INC. Logo
Develops gene-based drugs for chronic diseases, including treatments for heart failure.
United States of America LXRX
LIFECORE BIOMEDICAL, INC. \DE\ Logo
A CDMO for parenteral drugs, producing injectable-grade sodium hyaluronate (HA).
United States of America LFCR
Liminatus Pharma, Inc. Logo
Clinical-stage immuno-oncology firm developing cancer therapies targeting the CD47 checkpoint.
United States of America LIMN

Talk to a Data Expert

Have a question? We'll get back to you promptly.